Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies

Daniela Sia; Victoria Tovar; Agrin Moeini; Josep M. Llovet

doi:10.1038/onc.2012.617

Related publications

Article2015

Molecular Pathogenesis and Targeted Therapies for Intrahepatic Cholangiocarcinoma

Agrin Moeini, Daniela Sia, Nabeel Bardeesy, Vincenzo Mazzaferro, Josep M. Llovet

Clinical Cancer Research

Article2022

Molecular pathogenesis and systemic therapies for hepatocellular carcinoma

Josep M. Llovet, Roser Pinyol, Robin Kate Kelley, Anthony B. El-Khoueiry, Helen L. Reeves, Xin Wei Wang, Gregory J. Gores, Augusto Villanueva

Nature Cancer

Article2013

BASIC AND TRANSLATIONAL—BILIARY Integrative Molecular Analysis of Intrahepatic Cholangiocarcinoma Reveals 2 Classes That Have Different Outcomes

Daniela Sia, Yujin Hoshida, Augusto Villanueva, Sasan Roayaie, Joana Ferrer, Barbara Tabak, Judit Peix, Manel Solé, Victoria Tovar, Clara Alsinet, Helena Cornellà, Brandy Klotzle, Christian Cotsoglou, Swan N. Thung, Josep Fuster, Samuel Waxman, Jordi Bruix, Myron Schwartz, Rameen Beroukhim, Vincenzo Mazzaferro, Josep M. Llovet

Article2014

O100 DISCOVERY OF NOVEL MUTATIONS AND FUSION PROTEINS IN INTRAHEPATIC CHOLANGIOCARCINOMA

Daniela Sia, Bojan Losic, Laia Cabellos, Agrin Moeini, Kate Revill, Dennis M. Bonal, Ke Hao, Oriana Miltiadous, Z. Zhang, Yoshihiko Hoshida, Miluska Castillo, S. Roayaie, S N Thung, Marc Schwartz, Susannah Waxman, Carlos Cordon‐Cardo, Vincenzo Mazzaferro, Eric E. Schadt, Josep M. Llovet

Journal of Hepatology

Article2009

790 INTRAHEPATIC CHOLANGIOCARCINOMA IN CIRRHOTIC LIVER; ROLE OF DELAYED PHASES

Alejandro Forner, Jordi Rimola, Carmen Ayuso, R. Vilana, María Reig, Carlos Rodríguez de Lope, Josep M. Llovet, Jordi Bruix